Nika Pharmaceuticals, Inc (NIKA) shareholders
Close on Oct 16, 2026Market cap $431.19MP/E –Yield –
Ownership
Who owns Nika Pharmaceuticals's shares
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Dimitar Slavchev Savov | CEO, CFO, President, Director, 10% owner | 455,589,500 | 43.32% | Mar 19, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Dimitar Slavchev Savov CEO, CFO, President, Director, 10% owner | Mar 18, 2025 | Sale | −2,000,000 | $0.25 | $500.00K | 455,589,500 |
| Nika Pharmaceuticals, Inc President, CEO, CFO, Director, 10% owner | Jun 2, 2023 | Sale | −3,500,000 | $0.02 | $70.00K | – |
| Nika Pharmaceuticals, Inc President, CEO, CFO, Director, 10% owner | Jan 31, 2023 | Sale | −1,500,000 | $0.01 | $15.00K | – |
| Nika Pharmaceuticals, Inc President, CEO, CFO, Director, 10% owner | Jan 10, 2023 | Sale | −6,300,000 | $0.01 | $63.00K | – |
| Nika Pharmaceuticals, Inc President, CEO, CFO, Director, 10% owner | Oct 24, 2022 | Sale | −3,000,000 | $0.04 | $120.00K | – |
| Nika Pharmaceuticals, Inc President, CEO, CFO, Director, 10% owner | Sep 26, 2022 | Sale | −1,250,000 | $0.02 | $25.00K | – |
| Nika Pharmaceuticals, Inc President, CEO, CFO, Director, 10% owner | Sep 12, 2022 | Sale | −7,000,000 | $0.02 | $140.00K | – |
| Nika Pharmaceuticals, Inc Secretary, Director, 10% owner | Jul 20, 2022 | Other | +145,000,000 | – | – | – |
| Nika Pharmaceuticals, Inc President, CEO, CFO, Director, 10% owner | Jul 20, 2022 | Other | +333,181,000 | – | – | – |
| Nika Pharmaceuticals, Inc Secretary, Director, 10% owner | Apr 29, 2022 | Other | +5,000,000 | $50000.00 | $250.00B | 5,000,000 |
| Nika Pharmaceuticals, Inc President, CEO, CFO, Director, 10% owner | Apr 13, 2022 | Buy | +11,489,000 | $0.01 | $114.89K | – |
| Nika Pharmaceuticals, Inc President, CEO, CFO, Director, 10% owner | Apr 13, 2022 | Other | +10,000,000 | $3000000.00 | $30.00T | 10,000,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Nika Pharmaceuticals's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Dimitar Slavchev Savov Officer, Director, 10% Stockholder | Apr 16, 2025 | 10,000,000 | $10.00M | Apr 16, 2025 | Stock Purchase Agreement |
See a number that looks wrong?